Antisense Therapeutics Limited (AU:PER) has released an update.
Percheron Therapeutics Limited announces the appointment of Deborah Ambrosini as the new Chief Financial Officer and Company Secretary, highlighting her extensive experience in finance and the healthcare sector. Ambrosini’s previous roles have equipped her with deep expertise in regulatory compliance and corporate growth, poised to support Percheron’s expansion and investment initiatives. As Ambrosini steps into her role, she replaces Phillip Hains, who has been credited with significant contributions to the company’s development.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
